Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for Ultrafiltration in Peritoneal Dialysis
NCT04923295Phase 2Completed
- Sponsor
- An-Najah National University
- Start
- Jun 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dapagliflozin in Ultrafiltration Failure (UF), sponsored by An-Najah National University. Primary endpoints: Change from Baseline in the Mean Peritoneal Fluid Glucose ratio (D4/D0) at 4 weeks, Change from Baseline in the Mean Ultrafiltration Volume at 4 weeks and 2 more. Started Jun 2021; status: completed.
02
Drugs
dapagliflozin
03
Conditions
Ultrafiltration Failure (UF)
Beyond the preview
Go deeper on NCT04923295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04923295.